000			01937 a2200529 4500
005			20250517005007.0
264		0	_c20150806
008			201508s 0 0 eng d
022			_a1745-6215
024	7		_a10.1186/1745-6215-15-474 _2doi
040			_aNLM _beng _cNLM
100	1		_aVilgrain, Valérie
245	0	0	_aRadioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial. _h[electronic resource]
260			_bTrials _cDec 2014
300			_a474 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCarcinoma, Hepatocellular _xeconomics
650	0	4	_aClinical Protocols
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Costs
650	0	4	_aEmbolization, Therapeutic _xadverse effects
650	0	4	_aFrance
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xeconomics
650	0	4	_aMicrospheres
650	0	4	_aNiacinamide _xadverse effects
650	0	4	_aPhenylurea Compounds _xadverse effects
650	0	4	_aProspective Studies
650	0	4	_aProtein Kinase Inhibitors _xadverse effects
650	0	4	_aQuality of Life
650	0	4	_aResearch Design
650	0	4	_aSorafenib
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYttrium Radioisotopes _xadministration & dosage
700	1		_aAbdel-Rehim, Mohamed
700	1		_aSibert, Annie
700	1		_aRonot, Maxime
700	1		_aLebtahi, Rachida
700	1		_aCastéra, Laurent
700	1		_aChatellier, Gilles
773	0		_tTrials _gvol. 15 _gp. 474
856	4	0	_uhttps://doi.org/10.1186/1745-6215-15-474 _zAvailable from publisher's website
999			_c24426069 _d24426069